Atrish Bagchi, Ph.D., is a protein engineer and structural biologist currently working as a protein science lead at Evozyne. With extensive experience in developing antibody therapies for cancer and autoimmune diseases, Atrish previously held positions at Loxo Oncology @Lilly and the University of Pennsylvania, where significant contributions included the development of chimeric antigen receptor (CAR) T-cell therapies and detailed studies on Epidermal Growth Factor Receptor targeting. Atrish has a Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania and has established a strong track record in quantitative biochemical and biophysical techniques, contributing to innovations in immunotherapy and structural biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices